Obesity drugs in India : Obesity is growing rapidly worldwide. More than 100 crore people are struggling with this problem. This number is increasing. Obesity is also a serious problem in India. People adopt all kinds of measures to get rid of it. Nowadays, the trend of obesity reducing medicine is also going on fast. This is the reason that in the last five years, the market for obesity in the country has increased by four times, which can increase by 46% to Rs 22,800 crore by 2030.
Obesity
Weight loss drugs like Ozampic, Maunjaro, Vagoy are also becoming increasingly popular in foreign markets. However, due to global supply, low formulations of these medicines are not available in India, but their imported holes packs and optional drugs are getting plenty of sales in the country’s gray market. Companies making such medicines are planning to come here to take advantage of India’s growing obesity market.
These pharmaceutical companies are in the jugaad to come to India
Among them, America’s Elillili and Denmark’s Novo Nordix are prominent. Alilili can launch Terjetide (Maunjaro) in 2025 and Novo Nordix can launch Semaglutide in India by 2026. These medicines are showing effects in fighting obesity, but earlier they were made to treat type-2 diabetes. But now these weight management is being known as drugs.
Alan Musk is also praising
How to do obese medicine
Most of these medicines are taken through injections. They are used one day a week. Oral Semaglutile Tabblets, sold under the name Ribelsus, holds around 66% stake in the obesity market. There can be many challenges in India for these foreign companies. Most of the drugs of this category are beyond the purchase capacity of common Indians. Their one injection comes for 10-15 thousand rupees.
Obesity drug market in India
According to the report of Goldman Sachs, by 2030, the market for obesity can reach more than Rs 11.3 lakh crore, meaning $ 13,000 million. India’s obesity market has already increased four times in 5 years, which can increase by 46% annually to $ 262 million i.e. Rs 22,800 crore by 2030.
Disclaimer: Information provided here is only based on beliefs and information. It is important to tell here that Abplive.com No recognition, does not confirm the information. Before implementing any information or recognition, consult the concerned expert.
Also read: ‘I don’t have to live anymore …’ Deepika Padukone told students the story of her depression
Check out Below Health Tools-
Calculate your body mass index (BMI)
Calculate the age through age calculator
